You are here

JNJ

Covid vaccine roundup: US vaccine supplies grow, but experts warn of potential hiccups in supply chain; Emergent touts growing Covid vaccine capacity

Covid vaccine roundup: US vaccine supplies grow, but experts warn of potential hiccups in supply chain; Emergent touts growing Covid vaccine capacity

Endpoints

Moderna Therapeutics

Flag link:

Here's What the FDA Liked About Johnson & Johnson's COVID Vaccine

Here's What the FDA Liked About Johnson & Johnson's COVID Vaccine

Motley Fool

Flag link:

Biden invokes federal law to broker Merck, J&J Covid vaccine manufacturing alliance

Biden invokes federal law to broker Merck, J&J Covid vaccine manufacturing alliance

MedCity News

drug manufacturing

Flag link:

Merck, Johnson & Johnson to strike 'wartime' COVID-19 vaccine manufacturing deal: WaPo

Merck, Johnson & Johnson to strike 'wartime' COVID-19 vaccine manufacturing deal: WaPo

Fierce Pharma

drug manufacturing

Flag link:

J&J’s next COVID-19 vaccine challenge? Hurdling the ‘66%’ perception to win over a vaccine-hesitant public

J&J’s next COVID-19 vaccine challenge? Hurdling the ‘66%’ perception to win over a vaccine-hesitant public

Fierce Pharma

Flag link:

FDA authorizes Johnson & Johnson’s single-dose Covid-19 vaccine

FDA authorizes Johnson & Johnson’s single-dose Covid-19 vaccine

Stat

Emergency Use Authorization

Flag link:

FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy

FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy

Stat

Flag link:

2 Reasons the FDA Is Likely to Authorize the Johnson & Johnson Vaccine Next Week

2 Reasons the FDA Is Likely to Authorize the Johnson & Johnson Vaccine Next Week

Motley Fool

Emergency Use Authorization

Flag link:

Medtech’s haves and have-nots

Medtech’s haves and have-nots

EP Vantage

Boston Scientific

Flag link:

J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March

J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March

Marketwatch

Flag link:

U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine

U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine

Marketwatch

Flag link:

After Pfizer deal, Sanofi offers a hand to Johnson & Johnson for COVID-19 vaccine production

After Pfizer deal, Sanofi offers a hand to Johnson & Johnson for COVID-19 vaccine production

Fierce Pharma

Flag link:

As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing

As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing

Fierce Biotech

Flag link:

The Johnson & Johnson Vaccine Has Competition in the Race to Treat New Strains

The Johnson & Johnson Vaccine Has Competition in the Race to Treat New Strains

Motley Fool

COVID-19 variants

Flag link:

Fewer J&J vaccine doses means most Americans won't get shots until May or June, Fauci says

Fewer J&J vaccine doses means most Americans won't get shots until May or June, Fauci says

Beckers Hospital Review

Flag link:

Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected

Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected

Motley Fool

Flag link:

Janssen's COVID vaccine application submitted to EMA

Janssen's COVID vaccine application submitted to EMA

RAPS.org

Flag link:

1 Green Flag and 1 Red Flag for Johnson & Johnson's Vaccine Candidate

1 Green Flag and 1 Red Flag for Johnson & Johnson's Vaccine Candidate

Motley Fool

Flag link:

Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug

Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug

BioSpace

prostate cancer

clinical trials

Flag link:

Johnson & Johnson CEO: Our Covid-19 Vaccine Will Keep You From Getting ‘Very, Very Sick’

Johnson & Johnson CEO: Our Covid-19 Vaccine Will Keep You From Getting ‘Very, Very Sick’

Forbes

Flag link:

Pages